𝐑𝐞𝐜𝐚𝐥𝐥 𝐒𝐧𝐚𝐩𝐬𝐡𝐨𝐭 𝐢𝐧 𝐀𝐟𝐫𝐢𝐜𝐚

In just less than a month , multiple pharmaceutical products were recalled or flagged across several countries in #Africa ,for different reasons, but with one common goal: protecting patient safety.

For example,

=Azithromycin 500mg (Zimbabwe)

Recalled due to dissolution failure → potential reduced treatment effectiveness.

= Multiple Products (Malawi / Kenya / South Africa)

12 batches recalled because of quality defects (discoloration, contamination, manufacturing issues).

=MR.7 Super Capsules (Nigeria)

Full recall due to undeclared active pharmaceutical ingredients.

= Citro Soda Sachets (South Africa)

Recalled due to potential contamination.

Adport 1 mg,Nezra ,and Vanish 10/40 (Egypt)

Counterfeited batches found in the market

𝐖𝐡𝐚𝐭 𝐝𝐨𝐞𝐬 𝐭𝐡𝐢𝐬 𝐢𝐧𝐝𝐢𝐜𝐚𝐭𝐞?

This level of activity in just one week clearly reflects:

✔️ Strong momentum from National Regulatory Authorities (NRAs) toward

Market Surveillance & Control

✔️ Increasing pressure on markets to detect, react, and prevent risks faster

✔️ The critical importance of implementing #TrackandTrace systems

and executing clear Implementation Plans

= 𝐓𝐡𝐞 𝐛𝐢𝐠𝐠𝐞𝐫 𝐩𝐢𝐜𝐭𝐮𝐫𝐞

Nearly 10 African countries have already announced or are actively moving toward pharmaceutical traceability implementation.